Reviewed profile

food and beverage brand · public preview

TILOIB

Retail brand

Public category
Retail brand
Brand tier
challenger brand
Headquarters
Finland
Is this your company?Claim TILOIB to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to TILOIB — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What TILOIB covers.

TILT Biotherapeutics is a clinical-stage biotechnology company focused on developing oncolytic immunotherapies for the treatment of solid tumors. The company utilizes proprietary technology to engineer viruses that stimulate the immune system to recognize and attack cancer cells. Its lead investigational asset, TILT-123, is designed for intravenous delivery to target both primary and metastatic tumors.

  • Positioned as a challenger brand.
  • Headquartered in Finland.

FAQ

Questions this page answers.

What does TILOIB do?

TILOIB is a food and beverage brand based in Finland, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.